BRCA: Who Should Be Tested? Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out. by Sue Rochman FORWARD LOOK Screening for Lung Cancer in Rural Areas Programs aim to increase awareness of benefits. by Sue Rochman Cancer Takes an Unequal Toll on Employment In a study of women with breast cancer in North Carolina, those who lived in rural areas or were black were more likely than urban white women to report negative changes in their employment. by Pamela Rafalow Grossman First Ladies of Africa Issue Call to Address Cancer Crisis A coalition of wives of African leaders, originally dedicated to addressing HIV/AIDS, is now also taking on the growing problem of cancer. by Bradley D. Miller, PhD HIV Can Worsen Cancer Treatment Outcomes People with HIV who develop certain cancers are more likely to die from them than patients without HIV—even if they receive similar treatment. by Jon Kelvey Why Is the Rate of Uterine Cancer Rising? Uterine cancer incidence is increasing in the U.S., particularly in Hispanic, Asian and black women, but obesity may play a smaller role in this change than was previously assumed. by Ashley P. Taylor Cancer Care on a Native American Reservation For the first time, people living in the Navajo Nation who are diagnosed with cancer can get treated for the disease without leaving tribal lands. by Kate Yandell Risk Reduction, Clinical Trials Are Focus of Atlanta Community Event Cancer researchers, patient advocates and community members gathered for a public forum presented by the American Association for Cancer Research. by Kevin McLaughlin Getting a Read on Cancer Cancer patients are increasingly receiving treatments guided by the molecular characteristics of their cancer cells. But patients may have unequal access to testing and targeted therapies. by Kate Yandell Reinforcements for Cancer Research Scientific meeting emphasizes the importance of patient advocates in helping researchers to reduce cancer health disparities. by Marci A. Landsmann next Cancer Talk When Cancer Becomes an Unwanted Priority Amanda Rose Ferraro’s leukemia diagnosis forced her to spend time at the hospital away from her 3-year-old-son. She calls focusing on her health and leaving her son “the hardest thing I have ever had to do.” by Amanda Rose Ferraro New Drugs for an Elusive Cancer Target Medical oncologist and lung cancer expert Roy S. Herbst discusses early data on drugs that target a mutated form of the KRAS protein. by Anna Azvolinsky Clinical Trials: An African American Survivor’s Experience Melvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges. by Melvin Mann Food Insecurity and Cancer After discovering that some patients weren’t able to access the food they needed, a community oncology practice partnered with a local food bank. by Jen Tota McGivney More Posts